Emcure Pharmaceuticals Ltd (NSE:EMCURE) Share Price

Company Profile

Business description
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women’s Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.
Contact
Plot No. P-1 and P-2, IT-BT Park
Phase II, M.I.D.C.
Hinjawadi
PuneMH411 057
IND
T: +91 2035070033
https://www.emcure.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
11,474

Recommended

SpaceX has risen 50% from its IPO price to become the second-most-expensive stock under Morningstar’s coverage.

Tom Lauricella | 19 June 2026

Even as competition looks likely to build, the company remains a leading wide-moat business securely at the center of the AI ecosystem.

Brian Colello, CPA | 19 June 2026

Most Australians will end up owning SpaceX — whether they like it or not.

Tyger Fitzpatrick | 19 June 2026

Index	Last price	Change	% Change
All Ordinaries	9,045.50	27.70	-0.31%
CAC 40	8,467.98	37.19	0.44%
DAX 40	25,026.80	92.13	0.37%
Dow JONES (US)	51,564.70	72.15	0.14%
FTSE 100	10,399.70	108.91	-1.04%
HKSE	23,924.81	387.35	-1.59%
NASDAQ	26,517.93	496.28	1.91%
Nikkei 225	71,608.72	555.23	0.78%
NZX 50 Index	13,416.34	53.03	0.40%
S&P 500	7,500.58	80.48	1.08%
S&P/ASX 200	8,827.00	29.60	-0.33%
SSE Composite Index	4,090.48	17.59	-0.43%